Peng Shang Selected Research

Monoclonal Antibodies

1/2023	Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD.
10/2021	BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes.
1/2020	Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease.
5/2004	[Purification of colorectal cancer-associated antigen by immuno-affinity chromatography].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peng Shang Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 09/2003
14	Osteoporosis 10/2023 - 08/2011
12	Inflammation (Inflammations) 01/2023 - 10/2005
11	Bone Resorption 01/2023 - 01/2014
10	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 12/2010
10	Hepatocellular Carcinoma (Hepatoma) 04/2019 - 03/2003
5	Hypoxia (Hypoxemia) 01/2024 - 01/2015
5	Neoplasm Metastasis (Metastasis) 04/2019 - 03/2003
4	Bone Diseases (Bone Disease) 04/2024 - 12/2016
4	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 01/2018
4	Iron Overload 09/2021 - 09/2018
3	Postmenopausal Osteoporosis 01/2022 - 02/2015
2	Diarrhea 02/2024 - 03/2014
2	Eye Diseases (Eye Disease) 01/2023 - 10/2022
2	Infections 01/2023 - 05/2014
2	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2022 - 01/2021
2	Atherosclerosis 01/2022 - 03/2014
2	Wounds and Injuries (Trauma) 03/2021 - 10/2012
2	Ulcer 03/2021 - 10/2012
2	Poisoning 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 08/2020 - 01/2019
2	Fatigue 05/2020 - 03/2014
2	Persistent Hyperplastic Primary Vitreous 01/2020 - 01/2016
2	Bone Fractures (Bone Fracture) 01/2019 - 01/2018
2	Necrosis 12/2014 - 11/2012
1	Fibrosis (Cirrhosis) 12/2023
1	Tibial Fractures (Fracture, Tibial) 11/2023

Drug/Important Bio-Agent (IBA)

23	IronIBA 10/2023 - 01/2018
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2005
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2014
7	AntioxidantsIBA 01/2022 - 03/2013
5	Retinaldehyde (Retinal)IBA 01/2023 - 01/2020
4	Monoclonal AntibodiesIBA 01/2023 - 05/2004
4	AntigensIBA 10/2021 - 05/2004
4	Peptides (Polypeptides)IBA 01/2020 - 03/2003
3	Oxygen (Dioxygen)IBA 01/2024 - 01/2021
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 01/2020
3	ferric ammonium citrate FDA Link 01/2023 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2023 - 03/2007
3	HepcidinsIBA 01/2023 - 01/2019
3	Deferoxamine (Desferal)FDA LinkGeneric 01/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2019
3	Sirtuin 1IBA 04/2022 - 05/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2016
3	Chelating AgentsIBA 01/2022 - 09/2018
3	Methylnitronitrosoguanidine (MNNG)IBA 01/2022 - 01/2020
3	Crystallins (Crystallin)IBA 01/2020 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2015
3	Tartrate-Resistant Acid PhosphataseIBA 12/2019 - 02/2015
3	Polysaccharides (Glycans)IBA 07/2016 - 09/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2022
2	InterferonsIBA 01/2023 - 01/2023
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2023 - 01/2020
2	Aspartic Acid (Aspartate)FDA Link 01/2023 - 06/2015
2	Red Fluorescent ProteinIBA 01/2023 - 10/2021
2	Therapeutic UsesIBA 01/2023 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 01/2023 - 01/2020
2	Green Fluorescent ProteinsIBA 01/2023 - 10/2021
2	CollagenIBA 01/2023 - 10/2012
2	VinculinIBA 01/2023 - 01/2020
2	IntegrinsIBA 01/2023 - 01/2019
2	Beclin-1IBA 01/2023 - 10/2021
2	Lipocalin-2IBA 01/2023 - 03/2020
2	Retinal Pigments (Pigments, Visual)IBA 01/2023 - 10/2022
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022 - 01/2020
2	FluoridesIBA 01/2022 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 01/2020
2	CaspasesIBA 01/2022 - 12/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 01/2020
2	TubulinIBA 10/2021 - 01/2020
2	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 10/2008
2	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 10/2021 - 01/2020
2	DAPIIBA 10/2021 - 01/2020
2	Estrogens (Estrogen)FDA Link 09/2021 - 12/2016
2	EnzymesIBA 09/2021 - 01/2014
2	Ferritins (Ferritin)IBA 07/2021 - 06/2020
2	Messenger RNA (mRNA)IBA 11/2020 - 03/2015
2	Metformin (Glucophage)FDA LinkGeneric 08/2020 - 01/2019
2	phenethyl isothiocyanate (PEITC)IBA 08/2020 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 05/2020 - 01/2016
2	salinomycinIBA 01/2020 - 04/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 04/2019
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2015
2	Glutathione (Reduced Glutathione)IBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 05/2004
2	ElementsIBA 01/2018 - 10/2013
2	MicroRNAs (MicroRNA)IBA 06/2015 - 01/2015
2	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 02/2015 - 01/2014
1	Transcription Factors (Transcription Factor)IBA 01/2024
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2024
1	AmmoniaIBA 12/2023
1	Glia Maturation Factor (GMF)IBA 11/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	MelatoninIBA 01/2023

Therapy/Procedure

18	Therapeutics 04/2024 - 08/2011
3	Radiotherapy 01/2019 - 11/2017
2	Immunomodulation 03/2014 - 03/2013
1	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 02/2024
1	Hyperbaric Oxygenation 10/2023